Search for Clinical Trial Results

Sponsored By

Leukemia, Prolymphocytic - 55 Studies Found

Status Study
Completed Study Name: Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)
Condition: T-cell-prolymphocytic Leukemia
Date: 2010-08-20
Interventions:
  • Drug: Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab

Terminated Study Name: Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia
Condition: Prolymphocytic Leukemia
Date: 2006-01-24
Interventions:
  • Biological: rituximab
  • Drug: cyclophosphami
Completed Study Name: Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Condition: Prolymphocytic Leukemia
Date: 2006-01-16
Interventions:
  • Biological: alemtuzumab
  • Drug: cyclophospha
Terminated Study Name: Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Condition:
  • B-cell Chronic Lymphocytic Leukemia
  • Prolymphocytic Leukemia Date: 2004-12-07
    Interventions: Drug: alvocidib Other Names:
    • FLAVO
    • flavopiridol
    • HMR 1
Active, not recruiting Study Name: PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia
Condition:
  • Prolymphocytic Leukemia
  • Recurrent Small Lymphocytic Lymphoma Date: 2012-04-23
    Interventions:
    • Drug: ibrutinib Patients recei
Completed Study Name: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
Condition:
  • B-cell Chronic Lymphocytic Leukemia
  • Hematopoietic/Lymphoid Cancer
  • Drug: carfilzomib Given IV inf
Terminated Study Name: Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia
Condition:
  • B-cell Chronic Lymphocytic Leukemia
  • Prolymphocytic Leukemia Date: 2010-05-18
    Interventions:
    • Drug: alvespimycin hydrochloride

Terminated Study Name: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia
Condition:
  • Leukemia, Lymphoma, Chronic Lymphocytic
  • Leukemia, Prolymphocytic Date: 2007-12-21
    Interventions:
    • Drug: CAT-8015 5 mcg/kg Partic
Terminated Study Name: 17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Condition:
  • B-cell Chronic Lymphocytic Leukemia
  • Prolymphocytic Leukemia Date: 2004-12-07
    Interventions:
    • Drug: tanespimycin Given IV
Withdrawn Study Name: Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia
Condition:
  • Leukemia
  • Acute Lymphocytic Leukemia

Date: 2010-07-12
Interventions: Drug: Velcade IV Other Name: Bortezomib
Next >>>